ATE112316T1 - Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung. - Google Patents

Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.

Info

Publication number
ATE112316T1
ATE112316T1 AT92903034T AT92903034T ATE112316T1 AT E112316 T1 ATE112316 T1 AT E112316T1 AT 92903034 T AT92903034 T AT 92903034T AT 92903034 T AT92903034 T AT 92903034T AT E112316 T1 ATE112316 T1 AT E112316T1
Authority
AT
Austria
Prior art keywords
genome
dna sequences
sequences derived
production
application
Prior art date
Application number
AT92903034T
Other languages
English (en)
Inventor
Gerard Orth
Christoph Volpers
Rolf E Streeck
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE112316T1 publication Critical patent/ATE112316T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/084—Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92903034T 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung. ATE112316T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Publications (1)

Publication Number Publication Date
ATE112316T1 true ATE112316T1 (de) 1994-10-15

Family

ID=9403488

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903034T ATE112316T1 (de) 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.

Country Status (10)

Country Link
US (2) US5656423A (de)
EP (1) EP0563255B1 (de)
JP (1) JP3859696B2 (de)
AT (1) ATE112316T1 (de)
CA (2) CA2098819C (de)
DE (1) DE69104380T2 (de)
DK (1) DK0563255T3 (de)
ES (1) ES2062887T3 (de)
FR (1) FR2670797A1 (de)
WO (1) WO1992011369A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
CA2348413C (en) * 1998-10-26 2008-12-30 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (pap) smears
JP2002541822A (ja) * 1999-04-14 2002-12-10 エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント 組織特異的および病原体特異的毒性物質ならびにリボザイム
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
WO2003008649A1 (en) * 2001-07-20 2003-01-30 Board Of Regents, The University Of Texas System Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
AU2003270548B2 (en) 2002-09-09 2008-09-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
WO2004002416A2 (en) * 2002-06-26 2004-01-08 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
CA2539703C (en) 2003-09-25 2011-06-07 Third Wave Technologies, Inc. Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays
EP1708745B1 (de) 2003-12-23 2012-04-18 Arbor Vita Corporation Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
WO2006063065A2 (en) 2004-12-08 2006-06-15 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
JP4974899B2 (ja) * 2004-12-10 2012-07-11 ジェネラ バイオシステムズ リミテッド 組成物および検出方法
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8865162B2 (en) * 2008-06-13 2014-10-21 Oncohealth Corp. Monoclonal antibodies against HPV proteins
WO2010129821A1 (en) 2009-05-07 2010-11-11 Oncohealth Corporation Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
CN101730847B (zh) * 2007-04-05 2015-03-18 分类生物系统有限公司 组合物及检测方法
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers
US9376727B2 (en) * 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
FR2641081A1 (de) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
FR2670797B1 (de) 1994-08-19
DE69104380D1 (de) 1994-11-03
CA2098819A1 (fr) 1992-06-21
FR2670797A1 (fr) 1992-06-26
CA2375673C (fr) 2005-05-17
WO1992011369A1 (fr) 1992-07-09
DE69104380T2 (de) 1995-02-09
JPH06504672A (ja) 1994-06-02
US5656423A (en) 1997-08-12
EP0563255A1 (de) 1993-10-06
US5665535A (en) 1997-09-09
DK0563255T3 (da) 1994-10-24
EP0563255B1 (de) 1994-09-28
ES2062887T3 (es) 1994-12-16
JP3859696B2 (ja) 2006-12-20
CA2098819C (fr) 2002-06-18
CA2375673A1 (fr) 1992-07-09

Similar Documents

Publication Publication Date Title
ATE112316T1 (de) Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.
ATE152779T1 (de) Verfahren zur diagnose des menschlichen papillome-viruses typ-16 durch ''polymerase chain reaction''
DE68922336D1 (de) Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren.
ATE553201T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel
DK0637342T3 (da) Fremgangsmåde til typebestemmelse af HCV-isolater
EP1394256A3 (de) Genomische Sequenzen von HCV als Diagnostika und Therapeutika
ATE92746T1 (de) Polyether-abformmaterial, verfahren zu seiner herstellung und seine verwendung.
DE3682893D1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
DK502389A (da) Pyridazinonderivater og fremgangsmaade til fremstilling deraf
AU3054502A (en) Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
ES2123000T3 (es) Secuencias de adn del papilomavirus hpv 42 y su aplicacion en diagnostico.
DE69028951D1 (de) Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen
DE59808710D1 (de) Verfahren zur herstellung von 2-(3-pyrazolyl-oxymethylen)nitrobenzolen
TR199801039T2 (xx) Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul.
ATE461283T1 (de) Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
DE59008790D1 (de) Neisseria-spezifische DNA-Sonden.
ATE527376T1 (de) Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
FI98467B (fi) Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö
ES2048652B1 (es) Procedimientos de amplificacion de genoma para la deteccion e identificacion de secuencias genomicas relacionadas.
EP1309342A4 (de) Herstellung eines chimeren papillomavirus(22.01.2)
DE3764330D1 (de) 2,2;6,6-diethylen-3-oxo-17alpha-pregn-4-en-21, 17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharm. praeparate.
JPS5230715A (en) High chromium ferritic stainless steel
ATE104266T1 (de) 1-brom-3-chlor-1,2-diaryl-2-propanole, verfahren zur stereoselektiven herstellung der erythro-1- brom-3-chlor-1,2-diaryl-2-propanole und deren umsetzung zu azolylmethyloxiranen.
SE0103069L (sv) Användning av sond för nukleinsyra-hybridisering
DE59109185D1 (de) Verfahren zur Herstellung von 20-METHYL-5,7-PREGNADIEN-3 DOLLAR g(b),21-DIOL-DERIVATIVEN

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time